nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Temozolomide—brain cancer	0.399	0.486	CbGbCtD
Fosamprenavir—CYP3A4—Lomustine—brain cancer	0.339	0.414	CbGbCtD
Fosamprenavir—CYP3A4—Etoposide—brain cancer	0.0819	0.1	CbGbCtD
Fosamprenavir—Osteonecrosis—Procarbazine—brain cancer	0.0118	0.0696	CcSEcCtD
Fosamprenavir—Amprenavir—CYP2C9—brain cancer	0.0114	1	CrCbGaD
Fosamprenavir—Opportunistic infection—Temozolomide—brain cancer	0.00659	0.0389	CcSEcCtD
Fosamprenavir—Haemoglobin—Lomustine—brain cancer	0.00349	0.0206	CcSEcCtD
Fosamprenavir—Haemorrhage—Lomustine—brain cancer	0.00347	0.0205	CcSEcCtD
Fosamprenavir—Anorexia—Lomustine—brain cancer	0.00235	0.0139	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Carmustine—brain cancer	0.00229	0.0135	CcSEcCtD
Fosamprenavir—Body temperature increased—Carboplatin—brain cancer	0.00223	0.0132	CcSEcCtD
Fosamprenavir—Haemoglobin—Procarbazine—brain cancer	0.00222	0.0131	CcSEcCtD
Fosamprenavir—Haemorrhage—Procarbazine—brain cancer	0.0022	0.013	CcSEcCtD
Fosamprenavir—Inflammation—Etoposide—brain cancer	0.00219	0.0129	CcSEcCtD
Fosamprenavir—Decreased appetite—Lomustine—brain cancer	0.00214	0.0127	CcSEcCtD
Fosamprenavir—Neutropenia—Hydroxyurea—brain cancer	0.00199	0.0118	CcSEcCtD
Fosamprenavir—Body temperature increased—Lomustine—brain cancer	0.00195	0.0115	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00173	0.0102	CcSEcCtD
Fosamprenavir—Haemoglobin—Hydroxyurea—brain cancer	0.00171	0.0101	CcSEcCtD
Fosamprenavir—Haemorrhage—Hydroxyurea—brain cancer	0.00171	0.0101	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Temozolomide—brain cancer	0.0017	0.01	CcSEcCtD
Fosamprenavir—Myalgia—Procarbazine—brain cancer	0.00163	0.00965	CcSEcCtD
Fosamprenavir—Neutropenia—Carmustine—brain cancer	0.00161	0.00952	CcSEcCtD
Fosamprenavir—Vomiting—Lomustine—brain cancer	0.00157	0.00926	CcSEcCtD
Fosamprenavir—Neutropenia—Temozolomide—brain cancer	0.00156	0.0092	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Carmustine—brain cancer	0.00155	0.00918	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Temozolomide—brain cancer	0.0015	0.00887	CcSEcCtD
Fosamprenavir—Anorexia—Procarbazine—brain cancer	0.00149	0.00882	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00147	0.00869	CcSEcCtD
Fosamprenavir—Nausea—Lomustine—brain cancer	0.00147	0.00866	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00143	0.00843	CcSEcCtD
Fosamprenavir—Haemoglobin—Carmustine—brain cancer	0.00139	0.00819	CcSEcCtD
Fosamprenavir—Haemorrhage—Carmustine—brain cancer	0.00138	0.00815	CcSEcCtD
Fosamprenavir—Decreased appetite—Procarbazine—brain cancer	0.00136	0.00804	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Etoposide—brain cancer	0.00136	0.00803	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Carmustine—brain cancer	0.00136	0.00801	CcSEcCtD
Fosamprenavir—Fatigue—Procarbazine—brain cancer	0.00135	0.00798	CcSEcCtD
Fosamprenavir—Haemoglobin—Temozolomide—brain cancer	0.00134	0.00791	CcSEcCtD
Fosamprenavir—Haemorrhage—Temozolomide—brain cancer	0.00133	0.00787	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Temozolomide—brain cancer	0.00132	0.00777	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Temozolomide—brain cancer	0.00131	0.00774	CcSEcCtD
Fosamprenavir—Urethral disorder—Temozolomide—brain cancer	0.00131	0.00772	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Procarbazine—brain cancer	0.00128	0.00756	CcSEcCtD
Fosamprenavir—Erythema multiforme—Temozolomide—brain cancer	0.00126	0.00744	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00126	0.00742	CcSEcCtD
Fosamprenavir—Neutropenia—Etoposide—brain cancer	0.00125	0.00736	CcSEcCtD
Fosamprenavir—Abdominal pain—Procarbazine—brain cancer	0.00124	0.00731	CcSEcCtD
Fosamprenavir—Body temperature increased—Procarbazine—brain cancer	0.00124	0.00731	CcSEcCtD
Fosamprenavir—Cardiac disorder—Temozolomide—brain cancer	0.00124	0.00731	CcSEcCtD
Fosamprenavir—Immune system disorder—Temozolomide—brain cancer	0.0012	0.00711	CcSEcCtD
Fosamprenavir—Malnutrition—Carmustine—brain cancer	0.0012	0.00709	CcSEcCtD
Fosamprenavir—Nervous system disorder—Hydroxyurea—brain cancer	0.00119	0.00702	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00118	0.00696	CcSEcCtD
Fosamprenavir—Skin disorder—Hydroxyurea—brain cancer	0.00118	0.00695	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Etoposide—brain cancer	0.00117	0.00692	CcSEcCtD
Fosamprenavir—Myocardial infarction—Etoposide—brain cancer	0.00116	0.00688	CcSEcCtD
Fosamprenavir—Malnutrition—Temozolomide—brain cancer	0.00116	0.00685	CcSEcCtD
Fosamprenavir—Anorexia—Hydroxyurea—brain cancer	0.00116	0.00682	CcSEcCtD
Fosamprenavir—Hypersensitivity—Procarbazine—brain cancer	0.00115	0.00682	CcSEcCtD
Fosamprenavir—Asthenia—Procarbazine—brain cancer	0.00112	0.00664	CcSEcCtD
Fosamprenavir—Pruritus—Procarbazine—brain cancer	0.00111	0.00655	CcSEcCtD
Fosamprenavir—Diarrhoea—Procarbazine—brain cancer	0.00107	0.00633	CcSEcCtD
Fosamprenavir—Angioedema—Temozolomide—brain cancer	0.00106	0.00626	CcSEcCtD
Fosamprenavir—Decreased appetite—Hydroxyurea—brain cancer	0.00105	0.00622	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Etoposide—brain cancer	0.00105	0.00622	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00105	0.00618	CcSEcCtD
Fosamprenavir—Urethral disorder—Etoposide—brain cancer	0.00105	0.00618	CcSEcCtD
Fosamprenavir—Fatigue—Hydroxyurea—brain cancer	0.00104	0.00617	CcSEcCtD
Fosamprenavir—Dizziness—Procarbazine—brain cancer	0.00104	0.00612	CcSEcCtD
Fosamprenavir—Myalgia—Carmustine—brain cancer	0.00102	0.00604	CcSEcCtD
Fosamprenavir—Erythema multiforme—Etoposide—brain cancer	0.00101	0.00596	CcSEcCtD
Fosamprenavir—Vomiting—Procarbazine—brain cancer	0.000996	0.00588	CcSEcCtD
Fosamprenavir—Cardiac disorder—Etoposide—brain cancer	0.00099	0.00585	CcSEcCtD
Fosamprenavir—Myalgia—Temozolomide—brain cancer	0.000988	0.00583	CcSEcCtD
Fosamprenavir—Rash—Procarbazine—brain cancer	0.000987	0.00583	CcSEcCtD
Fosamprenavir—Dermatitis—Procarbazine—brain cancer	0.000987	0.00583	CcSEcCtD
Fosamprenavir—Headache—Procarbazine—brain cancer	0.000981	0.0058	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000981	0.00579	CcSEcCtD
Fosamprenavir—Immune system disorder—Etoposide—brain cancer	0.000963	0.00569	CcSEcCtD
Fosamprenavir—Body temperature increased—Hydroxyurea—brain cancer	0.000958	0.00566	CcSEcCtD
Fosamprenavir—Anorexia—Carmustine—brain cancer	0.000934	0.00552	CcSEcCtD
Fosamprenavir—Nausea—Procarbazine—brain cancer	0.00093	0.0055	CcSEcCtD
Fosamprenavir—Nervous system disorder—Temozolomide—brain cancer	0.000929	0.00549	CcSEcCtD
Fosamprenavir—Skin disorder—Temozolomide—brain cancer	0.00092	0.00543	CcSEcCtD
Fosamprenavir—Anorexia—Temozolomide—brain cancer	0.000903	0.00533	CcSEcCtD
Fosamprenavir—Hypersensitivity—Hydroxyurea—brain cancer	0.000893	0.00528	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Carmustine—brain cancer	0.000893	0.00527	CcSEcCtD
Fosamprenavir—Asthenia—Hydroxyurea—brain cancer	0.00087	0.00514	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000863	0.0051	CcSEcCtD
Fosamprenavir—Decreased appetite—Carmustine—brain cancer	0.000852	0.00503	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Carmustine—brain cancer	0.000846	0.005	CcSEcCtD
Fosamprenavir—Diarrhoea—Hydroxyurea—brain cancer	0.000829	0.0049	CcSEcCtD
Fosamprenavir—Decreased appetite—Temozolomide—brain cancer	0.000823	0.00486	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Temozolomide—brain cancer	0.000817	0.00483	CcSEcCtD
Fosamprenavir—Fatigue—Temozolomide—brain cancer	0.000816	0.00482	CcSEcCtD
Fosamprenavir—Dizziness—Hydroxyurea—brain cancer	0.000801	0.00473	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Carmustine—brain cancer	0.000801	0.00473	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000785	0.00464	CcSEcCtD
Fosamprenavir—Abdominal pain—Carmustine—brain cancer	0.000775	0.00458	CcSEcCtD
Fosamprenavir—Body temperature increased—Carmustine—brain cancer	0.000775	0.00458	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Temozolomide—brain cancer	0.000774	0.00457	CcSEcCtD
Fosamprenavir—Vomiting—Hydroxyurea—brain cancer	0.000771	0.00455	CcSEcCtD
Fosamprenavir—Rash—Hydroxyurea—brain cancer	0.000764	0.00451	CcSEcCtD
Fosamprenavir—Dermatitis—Hydroxyurea—brain cancer	0.000763	0.00451	CcSEcCtD
Fosamprenavir—Headache—Hydroxyurea—brain cancer	0.000759	0.00449	CcSEcCtD
Fosamprenavir—Abdominal pain—Temozolomide—brain cancer	0.000748	0.00442	CcSEcCtD
Fosamprenavir—Body temperature increased—Temozolomide—brain cancer	0.000748	0.00442	CcSEcCtD
Fosamprenavir—Skin disorder—Etoposide—brain cancer	0.000736	0.00435	CcSEcCtD
Fosamprenavir—Anorexia—Etoposide—brain cancer	0.000722	0.00427	CcSEcCtD
Fosamprenavir—Hypersensitivity—Carmustine—brain cancer	0.000722	0.00426	CcSEcCtD
Fosamprenavir—Nausea—Hydroxyurea—brain cancer	0.00072	0.00425	CcSEcCtD
Fosamprenavir—Asthenia—Carmustine—brain cancer	0.000703	0.00415	CcSEcCtD
Fosamprenavir—Hypersensitivity—Temozolomide—brain cancer	0.000698	0.00412	CcSEcCtD
Fosamprenavir—Asthenia—Temozolomide—brain cancer	0.000679	0.00401	CcSEcCtD
Fosamprenavir—Diarrhoea—Carmustine—brain cancer	0.00067	0.00396	CcSEcCtD
Fosamprenavir—Pruritus—Temozolomide—brain cancer	0.00067	0.00396	CcSEcCtD
Fosamprenavir—Decreased appetite—Etoposide—brain cancer	0.000659	0.00389	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Etoposide—brain cancer	0.000654	0.00386	CcSEcCtD
Fosamprenavir—Fatigue—Etoposide—brain cancer	0.000653	0.00386	CcSEcCtD
Fosamprenavir—Dizziness—Carmustine—brain cancer	0.000648	0.00383	CcSEcCtD
Fosamprenavir—Diarrhoea—Temozolomide—brain cancer	0.000648	0.00383	CcSEcCtD
Fosamprenavir—Dizziness—Temozolomide—brain cancer	0.000626	0.0037	CcSEcCtD
Fosamprenavir—Vomiting—Carmustine—brain cancer	0.000623	0.00368	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Etoposide—brain cancer	0.00062	0.00366	CcSEcCtD
Fosamprenavir—Rash—Carmustine—brain cancer	0.000618	0.00365	CcSEcCtD
Fosamprenavir—Dermatitis—Carmustine—brain cancer	0.000617	0.00365	CcSEcCtD
Fosamprenavir—Headache—Carmustine—brain cancer	0.000614	0.00363	CcSEcCtD
Fosamprenavir—Vomiting—Temozolomide—brain cancer	0.000602	0.00356	CcSEcCtD
Fosamprenavir—Abdominal pain—Etoposide—brain cancer	0.000599	0.00354	CcSEcCtD
Fosamprenavir—Body temperature increased—Etoposide—brain cancer	0.000599	0.00354	CcSEcCtD
Fosamprenavir—Rash—Temozolomide—brain cancer	0.000597	0.00353	CcSEcCtD
Fosamprenavir—Dermatitis—Temozolomide—brain cancer	0.000596	0.00352	CcSEcCtD
Fosamprenavir—Headache—Temozolomide—brain cancer	0.000593	0.0035	CcSEcCtD
Fosamprenavir—Nausea—Carmustine—brain cancer	0.000582	0.00344	CcSEcCtD
Fosamprenavir—Nausea—Temozolomide—brain cancer	0.000562	0.00332	CcSEcCtD
Fosamprenavir—Hypersensitivity—Etoposide—brain cancer	0.000558	0.0033	CcSEcCtD
Fosamprenavir—Asthenia—Etoposide—brain cancer	0.000544	0.00321	CcSEcCtD
Fosamprenavir—Pruritus—Etoposide—brain cancer	0.000536	0.00317	CcSEcCtD
Fosamprenavir—Diarrhoea—Etoposide—brain cancer	0.000518	0.00306	CcSEcCtD
Fosamprenavir—Dizziness—Etoposide—brain cancer	0.000501	0.00296	CcSEcCtD
Fosamprenavir—Vomiting—Etoposide—brain cancer	0.000482	0.00285	CcSEcCtD
Fosamprenavir—Rash—Etoposide—brain cancer	0.000478	0.00282	CcSEcCtD
Fosamprenavir—Dermatitis—Etoposide—brain cancer	0.000477	0.00282	CcSEcCtD
Fosamprenavir—Headache—Etoposide—brain cancer	0.000475	0.0028	CcSEcCtD
Fosamprenavir—Nausea—Etoposide—brain cancer	0.00045	0.00266	CcSEcCtD
